COMPLIANCE TO DRUG USE IN HYPERTENSIVE PATIENTS AND ITS RELATIONSHIP WITH VARIABLES AFFECTING IN THREE CITIES IN INDONESIA

  • MUHAMMAD MUHLIS Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • DEWI KARLINA Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • MERLI NAMITA Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • LALA MARESTA Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • YOCIKA ESTI FEROLIA Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia

Abstract

Objective: Patient noncompliance in taking medication is the problem in hypertension therapy. This study aims to describe the compliance to drug use in hypertensive patients in Bengkulu, Banjarmasin, and Yogyakarta, Indonesia.


Methods: This study is an observational study using a questionnaire, with a total sample size of 300. Data are analyzed by using bivariate analysis with the chi-square method to see if there is a relationship between compliance and predetermined variables.


Results: The study in three cities showed that there were 0 patients (0%) Low compliance and non-compliance category patients; the compliance category was 91%, 10%, 8%, respectively. High compliance categories were 9%, 90%, 92%. Chi-square test shows that compliance has a significant relationship (*P<0.05) in the three cities on the variable "treatment motivation", other variables that show a significant relationship in the city of Yogyakarta are "drug side effects", "role of health workers", "social support", in Bengkulu is "Therapeutic beliefs", in Banjarmasin is" Knowledge of therapeutic effects ".


Conclusion: All hypertensive patients have good compliance; compliance is significantly associated in all three cities on the variable "treatment motivation."

Keywords: Compliance, Hypertension, Influencing factors

References

1. Osamor PE, Owumi BE. Factors associated with treatment compliance in hypertension in southwest Nigeria. J Health Popul Nutr 2011;29:619-28.
2. Goodman and Gilman's. The pharmacological basis of therapeutics. Thirteenth Edition. USA: McGraw-Hill Education; 2018.
3. Tackling G, Borhade MB. Hypertensive heart disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
4. Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs 2019;79:365–79.
5. Sinha AD, Agarwal R. Clinical pharmacology of antihypertensive therapy for the treatment of hypertension in CKD. Clin J Am Soc Nephrol 2019;14:757–64.
6. Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. Br Med J 2016:352;i717.
7. Muhlis M, Prameswari A. Kepatuhan penggunaan obat pada pasien hipertensi di Instalasi Rawat Jalan Salah Satu RSUD di wilayah Daerah Istimewa Yogyakarta. Jurnal Insan Farmasi Indonesia 2020;3:104-13.
8. Gupta R, Guptha S. Strategies for initial management of hypertension. Indian J Med Res 2010;132:531–42.
9. Sinuraya RK, Destiani DP, Puspitasari IM, Diantini A. Pengukuran tingkat kepatuhan pengobatan pasien hipertensi di Fasilitas Kesehatan Tingkat Pertama di Kota Bandung. Indones J Clin Pharm 2018;7:124-33.
10. Dharan DR, Molly KT. Factors influencing compliance to therapeutic regimen among patients with hypertension. Asian J Pharm Clin Res 2017;10:286-9.
11. Mahmoud MIH. Compliance with the treatment of patients with hypertension in almadinah almunawwarah: a community-based study. J Taibah University Med Sci 2012;7:92-8.
12. Chusna N, Puspitasari I, Probosuseno P. Pengaruh kepatuhan dan pola pengobatan terhadap hasil terapi pasien hipertensi. J Management Pharm Pract 2014;4:230-5.
13. Rahmadani MA, Sari A. Kepatuhan terhadap pengobatan pada pasien hipertensi dengan komplikasi diabetes melitus di Puskesmas Yogyakarta. Media Farmasi 2018;15:1-5.
14. DiPiro JT, Spruill WJ, Wade WE, Blouin RA, Pruemer JM. Concepts in clinical pharmacokinetics. 5th Ed. Ohio: American Society of Health-System Pharmacists; 2010.
15. Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug information handbook. Ohio: Lexi-Comp Inc; 2007.
16. Jamaludin AN. Sosiologi perkotaan: memahami masyarakat kota dan problematikanya. Bandung: Penerbit CV Pustaka Setia; 2015.
17. Sari LT. Hubungan motivasi kesembuhan dengan kepatuhan minum obat pada penderita TB paru dewasa. JuKe 2019;3:1-8.
18. Hasan M. Hubungan motivasi kesembuhan dengan kepatuhan minum obat penderita tuberkulosis paru di puskesmas jambe kabupaten tangerang. J Penelitian Pengabdian Masy 2019;2:1-10.
19. Nuratiqa N, Risnah R, Hafid MA, Paharani A, Irwan M. Faktor yang berhubungan dengan kepatuhan minum obat anti hipertensi. BIMIKI 2020;8:1-10.
20. Varming AR, Hansen UM, Andresdottir G, Husted GR, Willaing I. Empowerment, motivation, and medical adherence (EMMA): the feasibility of a program for patient-centered consultations to support medication adherence and blood glucose control in adults with type 2 diabetes. Patient Prefer Adheren 2015;9:1243–53.
21. Nurhanani R, Susanto HS, Udiyono A. Hubungan faktor pengetahuan dengan tingkat kepatuhan minum obat antihipertensi (Studi pada pasien hipertensi essential di wilayah kerja Puskesmas Bandarharjo Kota Semarang). J Kes Masy 2020;8:114-21.
22. Rasajati Q, Raharjo B, Ningrum DN. Faktor-faktor yang berhubungan dengan kepatuhan pengobatan pada penderita hipertensi di wilayah kerja Puskesmas Kedungmundu Kota Semarang. Unnes J Pub Health 2015;4:16-23.
23. Khan MU, Shah S, Hameed T. Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland. J Pharm Bioallied Sci 2014;6:104-8.
Statistics
118 Views | 64 Downloads
Citations
How to Cite
MUHLIS, M., KARLINA, D., NAMITA, M., MARESTA, L., & FEROLIA, Y. E. (2021). COMPLIANCE TO DRUG USE IN HYPERTENSIVE PATIENTS AND ITS RELATIONSHIP WITH VARIABLES AFFECTING IN THREE CITIES IN INDONESIA. International Journal of Applied Pharmaceutics, 13(2), 59-61. https://doi.org/10.22159/ijap.2021.v13s2.11
Section
Original Article(s)